As shown in Figure 4a, the level of plasma CORT was enhanced when the rats were subjected to 21 days of CIS, which was significantly reversed by the administration of Xiaoyaosan or rosiglitazone (p < 0.001). This evidence concerns the gene CORT and in situ carcinoma.